NK Cell Chip-IHC from 3H Biomedical AB
UCB PDC Cell Chip-IHC from 3H Biomedical AB
Guanosine 5′-O-(2-Thiodiphosphate), Trilithium Salt from Calbiochem
Suramin, Sodium Salt from Calbiochem
Biology Products:(Date:11/30/2009)... , CHANGCHUN, China and LOS ANGELES, Nov....harmaceuticals, Inc. (OTC Bulletin Board: CYXN; ,C... leading manufacturer, distributor and,retailer of...unced it has,completed preparation for distributio... The Chinese government recently formalized the...
(Date:11/30/2009)... , SEATTLE, Nov. 30 /PRNewswire-FirstCall/... CTIC) announced today that its new class of plati...tes, demonstrated a stronger anti-tumor potency an...m-based compounds as well as the ability to overco... results were presented in a paper titled "Novel B...
(Date:11/30/2009)... , AMSTERDAM, Novem...ld,s,leading publisher of scientific, medical and ... major re-launch of Embase, its comprehensive biom...d records from more than 7,000,active, peer review...ey role in the advancement of new biomedical,and p...
(Date:11/27/2009)..., PARIS, November 27 /PRNewswire-FirstCall/...l to market Oralair(R) in both adults and children...the first country where,Oralair(R) has been market...lair(R) is now registered in Austria, Belgium, Bul..., Germany, Greece, Hungary, Ireland, Italy,Latvia...
Breaking Biology Technology:China Yongxin Pharmaceuticals Inc. to Distribute Medicines on the Essential Drug List 2China Yongxin Pharmaceuticals Inc. to Distribute Medicines on the Essential Drug List 3New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates, Demonstrates Potent Anti-Tumor Activity and Ability to Overcome Resistance to Currently Available Platinum-Based Agents 2New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates, Demonstrates Potent Anti-Tumor Activity and Ability to Overcome Resistance to Currently Available Platinum-Based Agents 3Elsevier is Re-Launching "Embase" to be a Powerful Resource Providing Deep Insights and Answers to Biomedical Researchers 2Elsevier is Re-Launching "Embase" to be a Powerful Resource Providing Deep Insights and Answers to Biomedical Researchers 3STALLERGENES is Granted a Marketing Authorization for Oralair(R) in Europe 2STALLERGENES is Granted a Marketing Authorization for Oralair(R) in Europe 3